-
-
-
-
-
-
-
XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics
-
-
-
-
-
-
-
NeuroNOS receives FDA orphan drug designation for glioblastoma treatment
-
-
-
-
-
-
-
Beyond Air's (XAIR) NeuroNOS receives FDA orphan drug designation for BA-102
-
-
-
-
-
-
-
Jones Trading Starts Beyond Air (XAIR) at Buy
-
-
-
-
-
-
-
Beyond Air, Inc. (XAIR) Provides LungFit PH System to U.S. Naval Hospital Guam
-
-
-
-
-
-
-
Beyond Air, Inc. (XAIR) Misses Q4 EPS by 133c
-
408,872 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

